Guardforce AI Co Stock (NASDAQ:GFAI), Trade Ideas

Guardforce AI Co

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

News

Penny Stocks

Contracts

General

GFAI

Security solutions provider Guardforce AI Co Ltd (NASDAQ: GFAI) said its subsidiary, Guardforce Cash Solutions Security (Thailand) Company Limited, has secured a three-year contract with a Japanese retailer for its end-to-end cash management solutions.

Guardforce AI Bags Contract From Japanese Retailer For Cash Management Solutions

Markets

Tech

Trading Ideas

CXAI

JTAI

LIDR

STIX

I&#39;m more of a talker than a writer so I&#39;ll let my video do the talking.

Micro Cap, Micro Float AI Stock That May Just Take Flight With The C3.AI ER On 9/6/2023 at 5Pm Est.

Small Cap

APLM

APRN

AURC

EGLE

GETY

HCTI

JOAN

LUNR

POLA

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a new focus of traders looking for the next huge move.

High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

10 Short Squeeze Stocks To Watch: Blue Apron, Intuitive Machines, Getty Images, Polar Power And More

Guardforce AI Co., Limited - Ordinary Shares

Guardforce AI Co Ltd

WIIM

ResMed shares are trading higher after the company reported better-than-expected Q3 financial results.

PINS

Pinterest shares are trading higher in sympathy with Snap, which reported better-than-expected Q1 financial results and issued Q2 revenue guidance above estimates

NatWest Group shares are trading higher. The company reported Q1 financial results.

SAIA

Saia Says Company's Executive Vice President And Chief Financial Officer, Douglas Col, Plans To Retire After 10 Years, Including Last Four Years At Company;  Col To Maintain Positions Until Company Announces Successor

Stifel analyst Brad Reback maintains Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Buy and raises the price target from $455 to $475.

Price Target

Analyst Ratings

MSFT

Stifel Maintains Buy on Microsoft, Raises Price Target to $475

Barclays analyst Matthew Bouley maintains Anywhere Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOUS#NYSE">HOUS</a>) with a Underweight and lowers the price target from $5 to $4.5.

HOUS

Barclays Maintains Underweight on Anywhere Real Estate, Lowers Price Target to $4.5

SNAP

Snap shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 revenue guidance above estimates. Also, the company reported a year-over-year increase in Q1 daily active users.

Stifel analyst J. Bruce Chan downgrades Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from Buy to Hold and lowers the price target from $53 to $47.

Downgrades

Stifel Downgrades Knight-Swift to Hold, Lowers Price Target to $47

Barclays maintains Accolade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) with a Equal-Weight and lowers the price target from $13 to $11.

ACCD

Barclays Maintains Equal-Weight on Accolade, Lowers Price Target to $11

ABBV

AbbVie shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY24 adjusted EPS guidance above estimates.

HSBC analyst Mohammed Khallouf upgrades Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) from Reduce to Hold.

Upgrades

HSBC Upgrades Snap to Hold

&#8220;Mad Money&#8221; host Jim Cramer pointed out the disproportionate coverage of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38381758/jim-cramer-weighs-in-after-iphone-sales-reportedly-plummet-19-in-china-in-q1-anothe">&#8220;losing leadership&#8221;</a> compared to Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) post their &#8220;spectacular quarters.&#8221;
What Happened: On Friday, Cramer took to X, formerly Twitter, to express his observation. He noted the abundance of articles discussing Apple&#8217;s recent struggles with <a href="https://www.benzinga.com/markets/equities/24/03/37872817/apple-says-dangerous-doj-lawsuit-threatens-who-we-are-vows-to-fight-against-it">antitrust regulations</a> and its latest product, Vision Pro, while <a href="https://www.benzinga.com/news/earnings/24/04/38445001/alphabet-q1-earnings-revenue-beat-eps-beat-70b-buyback-first-ever-dividend-ai-leadership-and-more">Google</a> and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38453639/another-picasso-like-performance-top-tech-analyst-praises-satya-nadella-says-micros">Microsoft&#8217;s remarkable quarterly results</a> barely made the news.
His post came after Alphabet and Microsoft released their earnings reports, both of which exceeded analyst expectations, while Apple&#8217;s iPhone sales in China plunged.
&#8220;There are hundreds of articles about Apple losing leadership but Google and Microsoft can barely buy an inch of ink after some spectacular quarters&#8230;&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">There are hundreds of articles about Apple losing leadership but Google and Microsoft can barely buy an inch of ink after some spectacular quarters&#8230;
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1783774623689011385?ref_src=twsrc%5Etfw">April 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/04/38392548/ups-earnings-show-the-weight-of-170-000-salaries-while-it-learns-to-navigate-shipping-slump?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">UPS Earnings Show The Weight Of $170,000 Compensation While It Learns To Navigate Shipping Slump</a>
Apple&#8217;s iPhone sales in China nosedived 19.1% in the first three months of 2024, with its market share witnessing a significant decline to 15.7% from 19.7% a year ago, according to data from Counterpoint Research.
This is Apple&#8217;s worst performance since 2020, largely due to the impact of Huawei Technologies Co.'s new <a href="https://www.benzinga.com/markets/equities/24/04/38308198/apples-falling-iphone-sales-have-another-challenge-to-deal-with-as-huawei-launches-new-phones" target="_blank" rel="noreferrer noopener">product launches</a> in the premium segment. Huawei's sales surged by 70% in the same period.
Why It Matters: Wall Street is eagerly anticipating <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38378204/apple-is-a-top-stock-pick-for-2024-analyst-says-4-catalysts-to-look-for-in-next-ear">Apple&#8217;s upcoming Q2 earnings</a> report, with analysts highlighting the stock&#8217;s promising outlook. Meanwhile, <a href="https://www.benzinga.com/news/earnings/24/04/38444199/microsoft-q3-earnings-revenue-beat-eps-beat-new-era-of-ai-transformation-and-more">Microsoft</a> and Alphabet have already reported impressive Q3 and Q1 earnings, respectively, beating both top and bottom-line estimates for five consecutive quarters.
Price Action: On Thursday, Apple closed at $169.89, Alphabet Inc. at $157.95, and Microsoft at $399.04, as per<a href="https://pro.benzinga.com"> Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/markets/equities/24/04/38384714/whats-going-on-with-trump-media-technology-stock-on-tuesday?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Trump Media &amp; Technology Stock On Tuesday?</a>
Image via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Analyst Color

Equities

AAPL

GOOG

GOOGL

Jim Cramer Says 'There Are Hundreds Of Articles' About Apple Losing Top Spot In China: 'Google And Microsoft Can Barely Buy An Inch Of Ink After Some Spectacular Quarters'

Charter currently expects full year 2024 capital expenditures to total between&nbsp;$12.2 billion&nbsp;and&nbsp;$12.4 billion, including line extensions capital expenditures of approximately&nbsp;$4.5 billion&nbsp;and network evolution spend of approximately&nbsp;$1.6 billion, compared to&nbsp;$4.0 billion&nbsp;and&nbsp;$0.9 billion, respectively, in 2023.

Guidance

CHTR

Charter Communications Reiterated 2024 Capex Outlook of $12.2B–$12.4B

Software giant Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) reported Thursday after the market close <a href="https://www.benzinga.com/news/earnings/24/04/38444199/microsoft-q3-earnings-revenue-beat-eps-beat-new-era-of-ai-transformation-and-more">strong third-quarter results,</a> sending its stock higher. 
On Cloud Nine: Microsoft attributed the strong quarterly performance, primarily to its Cloud business. &#8220;This quarter Microsoft Cloud revenue was $35.1 billion, up 23% year-over-year, driven by strong execution by our sales teams and partners,&#8221; CFO Amy Hood said in a statement.
Microsoft&#8217;s Azure public cloud and other cloud services saw both GAAP and constant currency revenue growth of 31%.
Speaking on the earnings call, CEO Satya Nadella said, &#8220;Azure again took share as customers use our platforms and tools to build their own AI solutions.&#8221; He also noted that more than 65% of the Fortune 500 now use Azure OpenAI service.&nbsp;
Commenting on the Azure performance, Piper Sandler&#8217;s Brent Bracelin said the 31% growth exceeded the guidance for a 28% increase and reinforced his bullish view that Microsoft remained &#8220;best-positioned to monetize robust AI secular tailwinds while capitalizing on a first-mover advantage.&#8221;
Bracelin estimated that Azure AI contributed over a $5 billion annualized run rate. 
See Also: <a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks">Best Artificial Intelligence Stocks</a>
Ancillary Beneficiaries: Calling Snowflake, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) and MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) as &#8220;Azure upside derivatives to watch,&#8221; Bracelin said these two companies have the most indirect exposure to consumption activity trends across the Cloud Titan cohort.
&#8220;Majority of revenue for SNOW is consumption-based while about 66% of revenue mix for MDB is consumption-based,&#8221; he said.
Bozeman, Montana-based Snowflake is a data-as-a-service company — backed by <a href="https://www.benzinga.com/news/large-cap/23/08/33611401/in-ai-we-trust-warren-buffett-sent-46-7-of-berkshire-hathaways-portfolio-there">Warren Buffett&#8216;s Berkshire Hathway</a> — offering a cloud-based data storage and analytics service and New York-based MongoDB is a provider of commercial support for the source-available database engine MongoDB.
In premarket trading on Friday, Snowflake rose 3.19% to $157.37&nbsp;and MongDB climbed 3.55% to $379.13, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data.</a> Microsoft rallied 4.34% to $416.34.
Read Next: <a href="https://www.benzinga.com/news/earnings/24/04/38455462/wall-street-futures-ride-high-on-microsoft-alphabet-cheer-but-will-inflation-data-burst-the-bubble-">Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn&#8217;t Over Yet</a>
Photo via Shutterstock

Long Ideas

SNOW

Microsoft's Azure Strength Could Rub Off On This Warren Buffett-Backed Stock And Another Big Cloud Player, Says Analyst

HCA Healthcare shares are trading lower. The company reported Q1 financial results.

Raymond James analyst Brian Gesuale upgrades Kratos Defense &amp; Security (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) from Outperform to Strong Buy and raises the price target from $20 to $27.

KTOS

Raymond James Upgrades Kratos Defense & Security to Strong Buy, Raises Price Target to $27

Enabled by high-capacity batteries, this key technology seeks to enhance security for users, ensure the conformity of all system components, and deliver an elevated boating experience.

VMAR

Vision Marine Technologies Says It Filed Patent For Advanced System Communication Encryption In E-Motion Powertrain

Needham analyst Laura Martin reiterates Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Buy and maintains $100 price target.

Reiteration

ROKU

Needham Reiterates Buy on Roku, Maintains $100 Price Target

Earnings

Large Cap

Health Care

AbbVie Is Raising Its 2024 Adjusted EPS Guidance From $10.97-$11.17 To $11.13-$11.33, Which Includes An Unfavorable Impact Of $0.08 Per Share Related To Acquired IPR&D And Milestones Expense, Versus Consensus Of $11.12

For the first quarter, the Company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $19.2 million with a GAAP net loss and Adjusted EBITDA loss between $(8.2) - $(7.0) million and $(1.0) - $(0.7) million, respectively (see definition of this non-GAAP measure and reconciliation to GAAP, below). The year-over-year revenue increase was primarily driven by strong organic growth due to our Dynamic Audience Activation Platform (DAAP) as well as from our October 2023 acquisition of Medicx Health.
Steve Silvestro, OptimizeRx President commented, "The momentum from the fourth quarter has carried into the first quarter of 2024 with the signing of 9 new DAAP deals. Current industry trends favor our approach with pharma looking to partner with scalable platforms that have agile precision-marketing capabilities which at its core is what our AI enabled platform delivers."
"Our commercial integration strategy between OptimizeRx and Medicx is also progressing ahead of our expectations, with numerous new cross-sell opportunities in late-stage negotiations. The integration of the two businesses is ahead of schedule and we are optimistic about our performance. With the addition of Medicx, we stand out as the only scalable platform with both HCP and direct-to-consumer reach. This unique positioning enhances our ability to cross-sell and upsell, unlocking significant value. We estimate the potential opportunity with existing brands alone to be nearly $2.8 billion, with even greater potential for brands we don't yet support. This favorable environment strengthens our confidence in meeting or exceeding our financial targets."

OPRX

OptimizeRx Corporation Says 1Q24 Revenue Expected To Grow Over 40% YoY And Come In Between $18.5M-$19.2M Vs. $17.03M Estimate; Company Says DAAP Adoption And Cross Selling Activities Are Tracking Ahead Of Internal Expectations

These Industrials stocks are trading higher:-Arq Inc (ARQ) stock is trading at $4.81, a gain of $1.33, or 37%, on high volume.  Arq Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.00.  -Nuscale Power Corp (SMR) stock is trad

Industrials Stocks Moving Up and Down Wednesday: ARQ, SMR, GFAI, POWL, EFSH, ZIM, VRME, LASE

Guardforce AI Co Ltd (GFAI) is lower by Thursday morning, with the stock decreasing -4.53% in pre-market trading to 3.58. GFAI's short-term technical score of 35 indicates that the stock has traded less bullishly over the last month than 65% of stocks on the market. In the Security and Protection Services industry, which r

Premarket Mover: Guardforce AI Co Ltd (GFAI) Down 4.53%

Solidion Technology, Tredegar, C3is among industrial movers

These Industrials stocks are trading higher:-Tredegar Corp (TG) stock is trading at $4.94, a gain of $0.94, or 23.69%, on high volume.  Tredegar Corp gets a Sentiment Score of Very Bearish from InvestorsObserver.  -Acacia Research Corp (ACTG) stock is trading at $4.59, a rise of $0.61, or 15.52%, on high volume.  Acacia Re

Industrials Stocks Moving Friday: TG, ACTG, GFAI, SMR, BW, PIXY, BLNK, RVSN

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
There are some sectors poised for gains that investors should keep on their radars. These sectors could grow as much as 20 times. Furthermore, I believe that this is a conservative estimate based on analyst projections.



I think that these sectors are relatively untapped. Some are more well-known and the growth story is obvious. While other sectors poised for gains are quietly flying under the radar, ready for investors to embrace them.



There are also industries and subsectors in this list that could be more accretive for investors than others. However, gaining 20 times or more involves considerable risk and speculation. Having said that, that door is also open for investors who have a suitable risk tolerance.



So here are three sectors poised for gains that could potentially mint new millionaires. I advise investors to have at least a small allocation to these. This is in order to improve their risk-adjusted returns and total returns.



<h2>Renewable Energy</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/greenenergy1600-300x169.jpg" alt="Green energy stocks"><div>Source: Shutterstock</div></div>This sector focuses on sustainable and eco-friendly energy sources like solar and wind power. I feel that despite this sector being an obvious growth sector, the companies within it trade at low valuations. There is great upside potential here.



Some companies to consider in this sector include First Solar (NASDAQ:<a href="https://investorplace.com/stock-quotes/fslr-stock-quote/">FSLR</a>), Brookfield Renewable Partners (NYSE:<a href="https://investorplace.com/stock-quotes/bep-stock-quote/">BEP</a>), or NextEra Energy (NYSE:<a href="https://investorplace.com/stock-quotes/nee-stock-quote/">NEE</a>). These brands have suffered from some short-term headwinds (particularly in Europe). However, these are gearing up for a stronger 2024 and beyond.



As investor dollars flow to sexier investments such as robotics and AI, I think that renewable energy could come out ahead of the broader indices such as the S&amp;P 500, as well as potentially 20x in value as the market matures.



With more than <a href="https://www.seia.org/solar-industry-research-data">50% of all new power</a> coming to the grid in the United States from solar last year, this is a trend that will only continue to develop in the future.



<h2>Information Technology</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/10/shutterstock_1034855800-300x169.png" alt="A photo of a satellite over earth."><div>Source: AlexLMX / Shutterstock</div></div>With that being said about renewables, my long-term thesis is that tech and information technology will continue to outperform all others for the foreseeable future. One reason of course is the explosion of AI. Companies like Microsoft (NASDAQ:<a href="https://investorplace.com/stock-quotes/msft-stock-quote/">MSFT</a>) and Nvidia (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>) leading the charge.



AI, for instance, is expected to be worth <a href="https://www.sphericalinsights.com/reports/america-artificial-intelligence-ai-market">more than half a trillion dollars</a> by 2032. Who knows how far this trend will stretch into the future. There&rsquo;s also the growth of the semiconductor industry, of which many companies in the Majestic Seven will benefit.



While the broad indices such as the Nasdaq are unlikely to make 20 times gains, specific companies in this sector, especially small caps and <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> certainly have this potential.



Analysts have highlighted these stocks for having multibagger potential. They include: Nerdy (NYSE:<a href="https://investorplace.com/stock-quotes/nrdy-stock-quote/">NRDY</a>), Himax Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/himx-stock-quote/">HIMX</a>), and Guardforce AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/gfai-stock-quote/">GFAI</a>).



<h2>Biotechnology</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600-300x169.png" alt="OLK Stock. Modern Medical Research Laboratory: Two Scientists Wearing Face Masks use Microscope, Analyse Sample in Petri Dish, Talk. Advanced Scientific Lab for Medicine, Biotechnology. Blue Color. KZR stock. RSLS stock. Best Biotech Stocks to Buy"><div>Source: Gorodenkoff / Shutterstock.com</div></div>The biotechnology sector, which includes companies focusing on genetic engineering, gene therapy, and pharmaceutical research, is advancing rapidly.



<a href="https://investorplace.com/industries/healthcare/biotech/">Biotech stocks</a> are particularly suited for investors seeking high-risk, high-return gains, with the valuations of these companies often changing 1,000% or more on trial results, product announcements, and other developments.&nbsp;



For those who are more conservative, one can also invest in broad-market ETFs such as the iShares Nasdaq Biotechnology ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/ibb-stock-quote/">IBB</a>) instead of buying shares in these risky penny stocks.



Still, as a rule of thumb, there is no potential for gain without a proportionate risk of loss, so to 20x your money, one must be prepared to pony up a sufficient amount of capital in a highly volatile investment.



Some promising industries within the biotech sector include <a href="https://worx1hr.com/fastest-growing-industries-top-5-sectors-by-2024/">genetic engineering, drug discovery, and personalized medicine</a>. Here you will find stocks capable of minting new millionaires with a sufficient investment.



On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"> InvestorPlace.com Publishing Guidelines</a>.
<div>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/millionaire-makers-3-sectors-poised-for-20x-gains/">Millionaire Makers: 3 Sectors Poised for 20X Gains</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Millionaire Makers: 3 Sectors Poised for 20X Gains

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
If you are after the most undervalued AI <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> to buy in April, you have come to the right place. This article will explore several small-cap companies working on cutting-edge artificial intelligence technologies that could see explosive growth as AI continues its rapid advancement.



AI has gone mainstream, with large language models like ChatGPT capturing the public&rsquo;s imagination. Some smaller, under-the-radar companies are also making significant strides in the AI space. I feel that due to their tiny valuations and market caps, they could one day become long-term winners.



While penny stocks are highly speculative and risky investments, they can also provide outsized returns if a company&rsquo;s technology and products gain traction. Specifically in the AI space, even small breakthroughs or partnerships could send share prices soaring for these thinly traded stocks.



So, here are the most undervalued AI penny stocks to buy in April. Don&rsquo;t miss out on these great options.



<h2>BigBear.ai (BBAI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/bbai1600-300x169.png" alt="BigBear.ai (BBAI) is a leading provider of high-speed decision-making technologies. They specialize in AI-driven analytics and solutions for critical missions"><div>Source: MacroEcon / Shutterstock.com</div></div>BigBear.ai (NYSE:<a href="https://investorplace.com/stock-quotes/bbai-stock-quote/">BBAI</a>) applies machine learning and AI in data analytics, offering significant growth potential.



In 2023, BBAI <a href="https://stockanalysis.com/stocks/bbai/statistics/">announced significant strategic developments,</a> including the successful acquisition of Pangiam. The acquisition aligns with BBAI&rsquo;s goal to create a comprehensive Vision AI portfolio. 



Financially, BBAI <a href="https://finance.yahoo.com/news/bigbear-ai-holdings-inc-bbai-033315789.html">reported</a> a net loss of $21.3 million in Q4 2023 but also marked its second consecutive quarter of positive adjusted EBITDA at $3.7 million. Revenue for Q4 2023 slightly increased to $40.6 million from $40.4 million in Q4 2022.



Looking ahead, things are also looking accretive for BBAI investors, with a revenue outlook for 2024 set between $195 million and $215 million.



I don&rsquo;t think investors can go wrong with considering BBAI stock to add to their AI penny stock portfolio for the above reasons. It&rsquo;s also cheap, trading at just 1.52 times forward sales, making it an undervalued option.



<h2>Bullfrog AI Holdings (BFRG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/08/mental_health_psychiatry_1600-300x169.jpg" alt='A row of file folders with labels reading "mental health," "psychiatry," "disorders", "bipolar," "depression," "anxiety" and "schizophrenia".'><div>Source: Olivier Le Moal / Shutterstock.com</div></div>Bullfrog AI Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfrg-stock-quote/">BFRG</a>) intersects AI with psychiatric treatment, aiming to change mental healthcare through technology. BFRG is pre-IPO, but at around $3 per share, it could be an undervalued AI pick for investors to consider. The company announced a <a href="https://ir.bullfrogai.com/news-events/press-releases/detail/40/bullfrog-ai-announces-pricing-of-5-7-million-public-offering">$5.7 million public offering</a> on February 1, with plans to use the proceeds for working capital and other general corporate purposes.&#8203;



Its main line of business is to use <a href="https://www.globenewswire.com/news-release/2024/01/17/2810580/0/en/BullFrog-AI-s-Collaboration-with-Lieber-Institute-for-Brain-Development-Yields-Potentially-Groundbreaking-Biological-Stratification-of-Brain-Expression-Data.html">AI to analyze gene expression data.</a> These include the identification of biological subtypes within disorders such as schizophrenia, bipolar disorder and major depressive disorder, offering new perspectives on personalized treatment strategies.



More broadly, the market is shifting away from cookie-cutter solutions in treatment and healthcare and more toward more personalized treatments. The aim is to reduce complications and adverse side effects. By some estimates, the <a href="https://www.grandviewresearch.com/industry-analysis/personalized-medicine-market">personalized medicine market</a> could be worth around $1 trillion by 2030. That makes BFRG undervalued when one considers its total addressable market.



<h2>Guardforce AI (GFAI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/04/gfai1600-300x169.png" alt="Stock Photo ID: 1659535744 Industrial technology concept. Container terminal. Logistics. Communication network. Secured logistics. GFAI stock."><div>Source: metamorworks / Shutterstock.com</div></div>Guardforce AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/gfai-stock-quote/">GFAI</a>) leverages AI technology across a wide range of information and security solutions, offering consulting services.



 The company <a href="https://www.globenewswire.com/news-release/2023/10/02/2752613/0/en/Guardforce-AI-Reports-Interim-Financial-Results-for-the-First-Half-of-2023-and-Provides-Business-Update.html">reported a net loss of $13.8 million</a> last year, alongside a basic and diluted loss per share of $4.35. The company&rsquo;s assets increased to $64.1 million from $61.2 million, with current assets including a significant rise in cash and cash equivalents from $6.9 million to $24.7 million.



Despite its influx of cash, it previously made some serious moves in the M&amp;A department. That includes acquiring robot-related business assets from Shenzhen Kewei Robot Technology, which I anticipate will help give it an edge in the market. GFAI&rsquo;s <a href="https://finance.yahoo.com/news/guardforce-ai-enters-definitive-agreement-140000908.html">press release about its acquisition</a> states that it includes the &ldquo;select equipment assets, client base in the sales pipeline and related sales channels and staff, as well as provide rights to the permanent use of its patents, thereby enhancing Guardforce AI&rsquo;s new Robot-as-a-Service (RaaS) sales and capabilities.&rdquo;



Finally, it may be undervalued. There are <a href="https://stockanalysis.com/stocks/gfai/statistics/">accounting profits</a> predicted by Wall Street analysts within the next 12 months and trading at just around 1 times sales at the time of writing suggests it is a good investment.



On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More: <a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">Penny Stocks &mdash; How to Profit Without Getting Scammed</a>



On the date of publication, Matthew Farley did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines.</a>
<div>Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/the-3-most-undervalued-ai-penny-stocks-to-buy-in-april-2024/">The 3 Most Undervalued AI Penny Stocks to Buy in April 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

The 3 Most Undervalued AI Penny Stocks to Buy in April 2024

Solidion Technology, XTI Aerospace, KWESST Micro Systems among industrial movers

XTI Aerospace, C3is, Solidion Technology among industrial movers

JanOne, C3is, ParaZero Technologies among industrial movers

ACTG

BBAI

BFRG

BLNK

CISS

EFSH

FLUX

FSLR

HIMX

LASE

NRDY

NVDA

PIXY

POWL

PRZO

RCRT

RVSN

SFWL

SHIM

SLND

UGRO

VRME

XTIA

IPOs

Press Releases

Guardforce AI Announces Pricing of $12.0 Million Underwritten Public Offering of Ordinary Shares

Guardforce AI Announces Closing of Underwritten Public Offering and Exercise of Full Over-Allotment Option

Guardforce AI Partners with Concorde Security Pte Ltd to Launch a New Robotic Security Solution in Singapore

Guardforce AI Secures Two-Year Contract for its End-to-End Cash Management Solution Including Guardforce Digital Machine in Thailand

Guardforce AI Reports Interim Financial Results for the First Half of 2023, and Provides Business Update

Guardforce AI Has Secured a Three-Year Contract with a Leading Japanese Retailer for its End-to-End Cash Management Solution Including Guardforce Digital Machine in Thailand

Guardforce AI Completes Conversion of $15.91 Million of Total Debt and Interest into Ordinary Shares at $5.40 Per Share

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

Opinion

Thinking about buying stock in Beyondspring, LAVA Therapeutics, Unicycive Therapeutics, Guardforce AI, or Infobird?

Events

Guardforce to Present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024